Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Terns Pharmaceuticals, Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-05-31
Purchase		2023-06-02
5:03 pm		Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer		9,997$1.41$14,09617,656
(Direct)		View
2023-05-31
Purchase		2023-06-02
5:03 pm		Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel		9,997$1.41$14,09617,656
(Direct)		View
2023-05-31
Purchase		2023-06-02
5:03 pm		Terns Pharmaceuticals Inc.TERNSundaram Senthil Vel
Chief Executive Officer		2,111$1.41$2,9779,770
(Direct)		View
2022-11-30
Purchase		2023-02-03
6:01 pm		Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel		3$1.41$4367,659
(Direct)		View
2022-11-30
Purchase		2023-02-03
6:01 pm		Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer		3$1.41$4367,659
(Direct)		View
2022-11-30
Purchase		2023-02-03
6:00 pm		Terns Pharmaceuticals Inc.TERNSundaram Senthil Vel
Chief Executive Officer		3$1.41$4907,659
(Direct)		View
2022-12-23
Purchase		2022-12-28
5:57 pm		Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
OrbiMed Genesis GP LLC
Director
10% Owner		137,931$7.25$1,000,0007,619,135
(Indirect)		View
2022-12-23
Purchase		2022-12-28
5:46 pm		Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner		137,931$7.25$1,000,0007,619,135
(Indirect)		View
2022-12-23
Purchase		2022-12-23
5:48 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		758,620$7.25$5,499,9956,657,992
(Indirect)		View
2022-12-23
Purchase		2022-12-23
5:44 pm		Terns Pharmaceuticals Inc.TERNLu Hongbo
Director		758,620$7.25$5,499,9954,340,212
(Indirect)		View
2022-11-23
Sale		2022-11-28
4:56 pm		Terns Pharmaceuticals Inc.TERNLAV Biosciences Fund V L.P.
Hopewell Resources Holdings Ltd
LAV Aqua Ltd
Oriental Spring Venture Ltd
10% Owner		1,500,000$5.5$8,250,0001,816,460
(Indirect)		View
2022-09-07
Purchase		2022-09-08
8:00 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		600,000$3.6$2,160,0005,899,372
(Indirect)		View
2022-09-07
Purchase		2022-09-08
8:00 pm		Terns Pharmaceuticals Inc.TERNLu Hongbo
Director		600,000$3.6$2,160,0003,581,592
(Indirect)		View
2022-08-16
Purchase		2022-08-18
5:00 pm		Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
OrbiMed Genesis GP LLC
Director
10% Owner		3,690,000$2.42$8,929,8001,072,400
(Indirect)		View
2022-08-16
Purchase		2022-08-18
4:50 pm		Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner		3,690,000$2.42$8,929,8001,072,400
(Indirect)		View
2022-08-12
Purchase		2022-08-16
8:44 pm		Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner		2,624,239$2.6599$6,980,2446,799,372
(Indirect)		View
2022-08-12
Purchase		2022-08-16
8:30 pm		Terns Pharmaceuticals Inc.TERNLu Hongbo
Director		2,624,239$2.6599$6,980,2444,481,592
(Indirect)		View
2022-05-31
Purchase		2022-06-08
9:28 pm		Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel		7,656$1.47$11,2547,656
(Direct)		View
2022-05-31
Purchase		2022-06-08
9:27 pm		Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer		7,656$1.47$11,2547,656
(Direct)		View
2022-05-31
Purchase		2022-06-08
9:27 pm		Terns Pharmaceuticals Inc.TERNSundaram Senthil Vel
Chief Executive Officer		7,656$1.47$11,2547,656
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-06-12
Option Award		2023-06-14
7:02 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNTaylor Ann Elizabeth
Director		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:02 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNTripuraneni Radhika
Director		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:02 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:01 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNFELLOWS DAVID A
Director		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:01 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:01 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNLu Hongbo
Director		32,000$032,000
(Direct)		View
2023-06-12
Option Award		2023-06-14
7:01 pm		N/A
2033-06-11		Terns Pharmaceuticals Inc.TERNKINDLER JEFFREY B
Director		32,000$032,000
(Direct)		View
2023-02-01
Option Award		2023-02-03
6:01 pm		N/A
2033-01-31		Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel		360,000$0367,659
(Direct)		View
2023-02-01
Option Award		2023-02-03
6:01 pm		N/A
2033-01-31		Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer		360,000$0367,659
(Direct)		View
2023-02-01
Option Award		2023-02-03
6:00 pm		N/A
2033-01-31		Terns Pharmaceuticals Inc.TERNQuirk Erin
President, Head of R&D		600,000$0600,000
(Direct)		View
2023-02-01
Option Award		2023-02-03
6:00 pm		N/A
2033-01-31		Terns Pharmaceuticals Inc.TERNSundaram Senthil Vel
Chief Executive Officer		900,000$0907,659
(Direct)		View
2022-07-26
Option Award		2022-07-28
8:08 pm		N/A
2032-07-25		Terns Pharmaceuticals Inc.TERNTripuraneni Radhika
Director		64,000$064,000
(Direct)		View
2022-07-01
Option Award		2022-07-06
8:07 pm		N/A
2032-06-30		Terns Pharmaceuticals Inc.TERNRussell Kerry Strong
Chief Medical Officer		240,000$0240,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNTaylor Ann Elizabeth
Director		32,000$032,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director		32,000$032,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNFELLOWS DAVID A
Director		32,000$032,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner		32,000$032,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNLu Hongbo
Director		32,000$032,000
(Direct)		View
2022-06-16
Option Award		2022-06-21
9:00 pm		N/A
2032-06-15		Terns Pharmaceuticals Inc.TERNKINDLER JEFFREY B
Director		32,000$032,000
(Direct)		View
2022-01-26
Option Award		2022-01-28
9:02 pm		N/A
2032-01-26		Terns Pharmaceuticals Inc.TERNQuirk Erin
President, CMO and Head of R&D		92,500$092,500
(Direct)		View
2022-01-26
Option Award		2022-01-28
9:02 pm		N/A
2032-01-26		Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer		65,000$065,000
(Direct)		View
Goto 0, 1, Next